Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): A report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)

British Journal of Haematology

Volumn 108, Issue 3, 2000, Pages 595-601

  Michallet, M ^a   Thiebaut A ^a   Dreger, P ^b   Remes, K ^c   Milpied, N ^d   Santini, G ^e   Hamon, M ^f   Bjorkstrand B ^g   Kimby, E ^g   Belhabri, A ^a   Tanguy, M L ^h   Apperley, J F ⁱ  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF KIEL   (Germany)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d HÔTEL DIEU   (France)

^e UNIVERSITY OF GENOA   (Italy)

^f PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Autotransplantation; CLL; Fludarabine; Mobilization; PBSC

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ARTICLE; AUTOTRANSPLANTATION; CELL COUNT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT GM; HUMAN; MOBILIZATION; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0034128720     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01900.x     Document Type: Article

References (43)

1. Bastion, Y., Felman, P., Dumontet, C., Espinouse, D. & Coiffier, B. (1992) Intensive radiochemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia. Bone Marrow Transplantation, 10, 467-468.
2. Binet, J.L., Catovsky, D., Chandra, P., Dighiero, G., Montserrat, E., Rai, K.R. & Sawitsky, A. (1981) Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. British Journal of Haematology, 48, 365-367.
3. Cheson, B.D., Bennett, J.M. & Grever, M. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-4997.
4. Dillman, R.O., Mick, R. & McIntyre, O.R. (1989) Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia Group B. Journal of Clinical Oncology, 7, 433-438.
5. Döhner, H., Stilgenbauer, S., James, M.R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W. & Lichter, P. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 2516-2522.
6. Dreger, P., Von Neuhoff, N., Kuse, R., Sonnen, R., Glass, B., Uharek, L., Schoch, R., Löffler, H. & Schmitz, N. (1998) Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure? British Journal of Haematology, 77, 2291-2297.
7. French Cooperative Group on Chronic Lymphocytic Leukaemia (1986) Effectiveness of CHOP regimen in advanced untreated chronic lymphocytic leukaemia. Lancet, i, 1346-1349.
8. French Cooperative Group on Chronic Lymphocytic Leukaemia (1989) Long term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. British Journal of Haematology, 73, 334-340.
9. French Cooperative Group on Chronic Lymphocytic Leukaemia (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. Lancet, 347, 1432-1438.
10. Hiddemann, W., Rottman, R. & Woman, B. (1991) Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase II study. Annals of Haematology, 63, 1-4.
11. Itala, M., Pelliniemi, T.T., Rajamaki, A. & Remes, K. (1997) Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplantation, 19, 647-651.
12. Juliusson, G., Oscier, D.G., Fitchett, M., Ross, F.M., Stockdill, G., Mackie, M.J., Parker, A.C., Castoldi, G.I., Cuneo, A., Knuutila, S., Elonen, E. & Gahrton, G. (1990) Prognostic subgroups in B-cell CLL defined by specific chromosomal abnormalities. New England Journal of Medicine, 323, 720-724.
13. Juliusson, G., Elmhorn-Rosenborg, A. & Liliemark, J. (1992) Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. New England loumal of Medicine, 327, 1056-1061.
14. Kantarjian, H.M., Smith, T. & Estey, E. (1992) Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. American Journal of Medicine, 93, 599-604.
15. Keating, M.J., Scouros, M. & Murphy, S. (1988) Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. Leukemia, 2, 157-164.
16. Keating, M.J., Kantarjian, H.M., O'Brien, S., Koller, C., Talpaz, M., Schachner, J., Childs, C., Freireich, E.J. & McCredie, K.B. (1991) Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology, 9, 44-49.
17. Keating, M.J., O'Brien, S., Kantarjian, H., O'Brien, S., Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M. & Freireich, E.J. (1993) Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood, 81, 2878-2884.
18. Keating, M.J., O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., Freireich, E.J., Estey, E. & Kantarjian, H. (1998) Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood, 92, 1165-1171.
19. Kefford, R.F. & Fox, R.M. (1982) Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosinotoxicity in non-replicating lymphocytes. British Journal of Haematology, 50, 627-636.
20. Khouri, I.F., Keating, M.J., Vriesendorp, H.M., Reading, C.L., Przepiorka, D., Huh, Y.O., Anderson, B.S., van Biesen, K.W., Mehra, R.C., Giralt, S.A., Ippoliti, C., Marshall, M., Thomas, M.W., O'Brien, S., Robertson, L.E., Deisseroth, A.B., Deisseroth, A.B. & Champlin, R.E. (1994) Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. Journal of Clinical Oncology, 12, 748-758.
21. McLaughlin, P., Hagemeister, F.B., Romaguera, J.E., Saris, A.H., Pate, O., Younes, A., Swan, F., Keating, M. & Cabanillas, F. (1996) Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. Journal of Clinical Oncology, 14, 1262-1268.
22. Michallet, M, Archimhaud, E., Rowlings, P.A., Bandini, G., Horowitz, M.M., Bortin, M.M., Atkinson, K., Deeg, J., Gahrton, G., Goldman, J.M., Jouet, J.P., Montserrat, E., Rai, K.R., Rozman, C., Speck, B., Gratwohl, A. & Gale, R.P. (1996) HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Annals of Internal Medicine, 124, 311-315.
23. Michallet, M., Van Biesen, A., Bandini, G., Carreras, E., Cornelissen, J.J., Dreger, P., Einsele, H., Gratwhol, A., Kimby, E., Niederwieser, D. & Appelerley, J. (1998) Hematopoietic stem cell transplantation for chronic lymphocytic leukemia (CLL). Bone Marrow Transplantation, 21, 73a.
24. Montserrat, E., Alcala, A. & Parody, R. (1985) Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine and prednisone. Cancer, 56, 2369-2375.
25. Montserralt, E., Sanchez-Bisono, J., Vinolas, N. & Rozman, C. (1986) Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. British Journal of Haematology, 62, 567-575.
26. Montserrat, E., Gomis, F., Vallespi, T., Rios, A., Romero, A., Soler, J., Alcala, A., Morey, M., Ferran, C., Diaz-Mediavilla, J., Flores, A., Woessner, S., Batelle, J., Gonzales-Aza, C., Rovira, M., Reverter, J.C. & Rozman, C. (1991) Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood, 78, 1545-1550.
27. Montserrat, E., Lopez-Lorenzo, J.L. & Manso, F. (1996) Fludarabine in resistant B-cell chronic lymphocytic leukemia. The Spanish Group experience. Leukemia and Lymphoma, 21, 467-472.
28. O'Brien, S., Kantarjian, H., Beran, M., Smith, T., Koller, C., Estey, E., Robertson, L.E., Lerner, S. & Keating, M. (1993) Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with a multivariate analysis-derived prognostic model for response to treatment. Blood, 82, 1695-1700.
29. O'Brien, S., Kantarjian, H., Beran, M., Freireich, E., Kornblau, S., Koller, C., Lerner, S., Gilbreath, J. & Keating, M. (1996) Fludarabine (FAMP) and cyclophosphamide (CTS) therapy in chronic lymphocytic leukemia (CLL) (Abstract). Blood, 88, 480a.
30. Provan, D., Barlett-Pandite, L., Zwicky, C., Neuberg, D., Maddocks, A., Corradini, P., Soiffer, R., Ritz, J., Nadler, L.M. & Gribben, G. (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood, 88, 2228-2235.
31. Rabinowe, S.N., Soiffier, R.J., Gribben, J., Daley, H., Freedman, A.S., Daley, J., Pesek, K., Neuberg, D., Pinkus, G., Leavitt, P.R., Spector, N.A., Grossbard, M.L., Anderson, K., Robertson, M.J., Mauch, P., Chayt-Marcus, K., Ritz, J. & Nadler, L.M. (1993) Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic leukemia. Blood, 4, 1366-1376.
32. Rai, K.R., Peterson, B., Elias, L., Shepherd, L., Hines, J., Nelson, D., Cheson, B., Kolitz, J. & Schiffer, C.A. (1996) A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia: a CALGB, SWOG, CTG/NCI-C and ECOG intergroup study (Abstract). Blood, 88, 141a.
33. Robertson, LE., O'Brien, S. & Kantarjian, H. (1995) Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia. Leukemia, 9, 943-945.
34. Rozman, D. & Montserrat, E. (1988) Bone marrow biopsy in chronic lymphocytic leukemia. Nouvelle Review Française d'Hématologie, 30, 369.
35. Rozman, D., Montserrat, E., Rodriguez-Fernandez, J.M., Ayats, R., Vallespi, T., Parody, R., Rios, A., Prados, D., Morey, M., Gomis, F., Alcala, A., Gutierrez, M., Maldonado, J., Gonzalez, C., Giralt, M., Hernadez-Nieto, L., Cabrera, A. & Fernandez-Ranada, J.M. (1984) Bone marrow histologic pattern - the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood, 64, 642-650.
36. Sala, R., Mauro, F.R., Bellucci, R., De Propis, M.S., Cordone, I., Lisa, A., Foà, R. & De Fabritis, P. (1998) Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukemia before and after chemotherapy. European Journal of Haematology, 61, 14-20.
37. Sarfati, M., Chevret, S., Chastang, C., Biron, G., Stryckmans, P., Delespesse, G., Binet, J.L., Merie-Beral, H. & Bon, D. (1996) Prognostic importance of serum soluble DD23 level in chronic lymphocytic leukemia. Blood, 88, 4259-4264.
38. Saven, A., Lemon, R.H., Kosty, M., Beutler, E. & Piro, L.D. (1995) 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. Journal of Clinical Oncology, 13, 570-574.
39. Sawitski, A., Rai, K.R., Glidewell. O. & Silver, R.T. (1977) Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood, 50, 1049-1059.
40. Scalzulli, P.R., Musto, P., Dell'Olio, M. & Carotenuto, M. (1996) CFU-GM are not increased in peripheral blood of patients with chronic lymphocytic leukemia. European Journal of Haematology, 57, 180-181.
41. Silber, R., & Stahl, A. (1990) Chronic lymphocytic leukemia and related diseases. Hematology, 4th edn (ed. by W. Williams, E. Beutler, A.J. Erslev, et al). McGraw-Hill, New York, pp. 1005-1025.
42. Sorensen, J.M., Vena, D.A., Fallavollita, A., Chun, H.G. & Cheson, B.D. (1997) Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. Journal of Clinical Oncology, 15, 458-465.
43. Tsatalas, C., Chalkia, P. & Athanasiadis, C. (1995) Increased peripheral blood normal myeloid progenitor cells (CFU-GM) in chronic lymphocytic leukemia: a perspective for autologous peripheral blood stem cell transplantation. European Journal of Haematology, 54, 235-240.